Independent report

PPRS Dispute Resolution Panel decisions

Pharmaceutical Price Regulation Scheme (PPRS) Dispute Resolution Panel decisions.

• From: Department of Health and Social Care
• Published: 15 June 2015
• Last updated: 4 March 2016
  Show all updates

  1. 4 March 2016

     Updated with PPRS Dispute Resolution Panel decision for DH and Novartis Pharmaceuticals UK Ltd.

  2. 15 June 2015

     First published.

Documents

Department of Health and Novartis Pharmaceuticals UK Ltd: decision 9 February 2016

PDF, 312 KB, 6 pages

Department of Health and Pfizer Ltd: decision 7 April 2015

PDF, 349 KB, 14 pages

Department of Health and Takeda UK Ltd: decision 5 June 2013

PDF, 330 KB, 7 pages

Department of Health and Bayer PLC: decision 20 May 2013

PDF, 253 KB, 9 pages

Department of Health and Sanofi Pasteur MSD Ltd: decision 3 January 2013

PDF, 188 KB, 8 pages

Department of Health and Merck Serono Ltd: decision 18 May 2012

PDF, 231 KB, 11 pages

Department of Health and Teva UK Ltd: decision 18 May 2012

PDF, 230 KB, 11 pages

Details

The PPRS Dispute Resolution Panel operates under the 2014 Pharmaceutical Price Regulation Scheme to consider and provide reasoned decisions for disputes under the 2014, 2009, 2008 and 2005 Schemes.

This page will be updated to include all dispute decisions.

Dispute decisions issued in 2011 are available.